| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/09/2007 | EP1781101A2 Novel nucleoside derivatives |
| 05/09/2007 | EP1781097A2 Liver disease-related methods and systems |
| 05/09/2007 | EP1711169B1 Extended release coated minitablets of venlafaxine hydrochloride |
| 05/09/2007 | EP1682530B1 Pyrrole substituted indoles as inhibitors of pai-1 |
| 05/09/2007 | EP1654229B1 Piperidine derivatives as ccr5 receptor modulators |
| 05/09/2007 | EP1599478B1 Dihydropteridinones, method for the production and use thereof in the form of drugs |
| 05/09/2007 | EP1597238B1 Hiv replication inhibiting pyrimidines and triazines |
| 05/09/2007 | EP1589967B1 Benzthiazole-3 oxides useful for the treatment of proliferative disorders |
| 05/09/2007 | EP1578420A4 Treatment of cognitive impairment using a selective dopamine d1 receptor agonist |
| 05/09/2007 | EP1572675B1 New alpha-glucosidase inhibitors and their synthesis from a natural source |
| 05/09/2007 | EP1572667B1 Cathepsin cysteine protease inhibitors and their use in the treatment of inflammation and immune disorders |
| 05/09/2007 | EP1565451B1 Halothienoyl-cyclopropane-1-carboxylic acid derivatives |
| 05/09/2007 | EP1551369A4 Combination therapy for treatment of fibrotic disorders |
| 05/09/2007 | EP1545511B1 Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder |
| 05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 05/09/2007 | EP1487469A4 Co-beadlet of dha and rosemary and methods of use |
| 05/09/2007 | EP1487434B1 Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin |
| 05/09/2007 | EP1450799B9 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 05/09/2007 | EP1446131B1 Use of specific dose of fondaparinux sodium for the treatment of acs |
| 05/09/2007 | EP1435874A4 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
| 05/09/2007 | EP1408970B1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment |
| 05/09/2007 | EP1408941B1 Use of a pharmaceutical composition comprising two quaternary ammonium compounds and an organometallic one in the treatment of viral and fungal infections and diseases |
| 05/09/2007 | EP1406883B1 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3) |
| 05/09/2007 | EP1401503B1 Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug and a solubility-enhancing polymer |
| 05/09/2007 | EP1383489B1 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 05/09/2007 | EP1364959B1 Crystal of pyrimidine nucleoside derivative |
| 05/09/2007 | EP1355542B1 Nutritional composition with health promoting action containing oligosaccharides |
| 05/09/2007 | EP1313882B1 Diagnosis and treatment of prostate cancer |
| 05/09/2007 | EP1272477B1 Pyrimidine compounds |
| 05/09/2007 | EP1268441B1 An intermediate and process for its synthesis |
| 05/09/2007 | EP1265907B9 Novel aryl fructose-1,6-bisphosphatase inhibitors |
| 05/09/2007 | EP1254907B1 Pyrrolopyridazine compound |
| 05/09/2007 | EP1244456B1 A pyrrolidineacetamide derivative for treatment of chronic or neuropathic pain |
| 05/09/2007 | EP1238970B9 Cycloamine ccr5 receptor antagonists |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | EP1183245B1 Selective npy (y5) antagonists |
| 05/09/2007 | EP1180143B1 In vitro methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues, pharmaceutical compositions related thereto |
| 05/09/2007 | EP1168912B1 Organ arrest, protection and preservation |
| 05/09/2007 | EP1166652B1 Utilization of material containing docosapentaenoic acid |
| 05/09/2007 | EP1163274B9 Process for cross-linking hyaluronic acid to polymers |
| 05/09/2007 | EP1156829B1 Stable formulation containing fumagillin |
| 05/09/2007 | EP1126855B1 Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons |
| 05/09/2007 | EP1093337B1 Food supplements comprising lipoic acid and creatine and methods for their use |
| 05/09/2007 | EP1041992A4 Hyperhydrated citicoline, process and use |
| 05/09/2007 | EP1036078B1 Thienopyrimidines |
| 05/09/2007 | EP0969720B1 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/09/2007 | EP0937032B1 Substituted gamma aminobutyric acids as pharmaceutical agents |
| 05/09/2007 | EP0853450B1 Compositions for the treatment of vascular injury |
| 05/09/2007 | EP0711177B1 Improvements relating to the preparation of prodrugs |
| 05/09/2007 | EP0708660B1 Compounds useful for preparing prodrugs of protein tyrosine kinase inhibitors |
| 05/09/2007 | CN2897057Y Health-care quilt-tube with fragrant medicinal bag |
| 05/09/2007 | CN1961027A Novel water-soluble fullerene, process for producing the same and active oxygen generator containing the fullerene |
| 05/09/2007 | CN1960995A Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes |
| 05/09/2007 | CN1960994A Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
| 05/09/2007 | CN1960993A 6,6-bicyclic substituted heterobicyclic protein kinase inhibitors |
| 05/09/2007 | CN1960991A Tetrahydro-imidazo [1,5-A] pyridin derivatives as aldosterone synthase inhibitors |
| 05/09/2007 | CN1960989A Substituted oxazolobenzoisothiazole dioxide derivatives, production method and use thereof |
| 05/09/2007 | CN1960988A Compounds and compositions as protein kinase inhibitors |
| 05/09/2007 | CN1960986A Butyrylcholinesterase selective inhibitors |
| 05/09/2007 | CN1960985A Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 05/09/2007 | CN1960984A Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists |
| 05/09/2007 | CN1960983A Arylsulfonyl benzodioxanes useful for modulation the 5-HT6 receptor, the 5-HT2areceptor or both |
| 05/09/2007 | CN1960981A Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 05/09/2007 | CN1960980A Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (VMS) |
| 05/09/2007 | CN1960979A Triazolone derivatives as MMP inhibitors for the treatment of asthma and copd |
| 05/09/2007 | CN1960977A Quinazoline derivative |
| 05/09/2007 | CN1960976A 4-carbox pyrazole derivates useful as anti-viral agents |
| 05/09/2007 | CN1960975A Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 05/09/2007 | CN1960974A Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/09/2007 | CN1960973A 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine(NE) and the serotonine(5-HT) activity and the monoamine reuptake |
| 05/09/2007 | CN1960972A Process for forming amorphous atorvastatin calcium |
| 05/09/2007 | CN1960971A Substituted pyrrolidine-2-ones |
| 05/09/2007 | CN1960969A Histamine H3 receptor agents, preparation method and therapeutic uses thereof |
| 05/09/2007 | CN1960966A Hydrazide-containing CFTR inhibitor compounds and uses thereof |
| 05/09/2007 | CN1960959A Practical, cost-effective synthesis of ubiquinones |
| 05/09/2007 | CN1960825A Functionalized colloidal metal compositions and methods |
| 05/09/2007 | CN1960781A Therapeutic combination for treatment of alzheimers disease |
| 05/09/2007 | CN1960763A Anti-vaginitis compositions |
| 05/09/2007 | CN1960762A Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 05/09/2007 | CN1960761A Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 05/09/2007 | CN1960760A Combinations comprising antimuscarinic agents and corticosteroids |
| 05/09/2007 | CN1960759A Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 05/09/2007 | CN1960742A Drug for ameliorating male climacteric disorder |
| 05/09/2007 | CN1960737A Treatment with oxaliplatin and EGFR-inhibitor |
| 05/09/2007 | CN1960736A Anti-infectious hydrogel compositions |
| 05/09/2007 | CN1960735A Use of drug combinations for treating insulin resistance |
| 05/09/2007 | CN1960734A Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin |
| 05/09/2007 | CN1960733A Combination product comprising SRC kinase inhibitor AZD0530 and an antioestrogen or EGFR-TK-inhibitor |
| 05/09/2007 | CN1960732A Treatment with gemcitabine and EGFR-inhibitor |
| 05/09/2007 | CN1960731A Method for regulating inflammatory and metastatic processes |
| 05/09/2007 | CN1960730A Treatment with irinotecan and EGFR-inhibitor |
| 05/09/2007 | CN1960729A 伊立替康制剂 Irinotecan preparations |
| 05/09/2007 | CN1960728A Conformationally constrained SMAC mimetics and the uses thereof |
| 05/09/2007 | CN1960727A Naphthalene derivatives useful as histamine-3-receptor ligands |
| 05/09/2007 | CN1960726A Composition comprising a jnk inhibitor and cyclosporin |
| 05/09/2007 | CN1960725A Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis |
| 05/09/2007 | CN1960724A Use of rotigotine for treating and preventing parkinson's plus syndrome |
| 05/09/2007 | CN1960723A Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight |
| 05/09/2007 | CN1960722A Use of furan alkyl for preparing an antidiabetic drug |
| 05/09/2007 | CN1960721A C7 lactyloxy-substituted taxanes |